Charles Spicer

Dr. Charles A. Spicer is a Non-Executive Chairman at CRISM Therapeutics Corp., an Independent Non-Executive Chairman at EMV Capital Plc, an Operating & Advisory partner at Gyrus Capital SA, an Advisor at Science Creates Ventures LLP, a Chairman at Creo Medical Ltd., a Chairman at Trust William Ltd., a Chairman-Product Development Awards Selection of United Kingdom Department of Health & Social Care, a Member at Health Innovation Challenge Fund and a Non-Executive Chairman at Korn Wall Ltd. He is on the Board of Directors at The Royal Humane Society and The Fishmongers Co. Dr. Spicer was previously employed as a Senior Independent Director by MJ Hudson Group Plc, a Principal by City & Guilds Group, a Non-Executive Chairman by Creo Medical Group Plc, a Non-Executive Chairman by Ixico Plc, a Non-Executive Chairman by Realm Therapeutics Plc, an Independent Non-Executive Director by Ark Therapeutics Group Plc, a Non-Executive Director by Aircraft Medical Ltd., a Chief Executive Officer by MDY Healthcare Plc, an Associate Director by Daniel Stewart & Co. Plc, a Principal by Bear Stearns & Co. Ltd., a Non-Executive Chairman by 11 Health & Technologies Ltd., a Head-Healthcare Corporate Finance by Numis Securities Ltd., and a Non-Executive Director by Varex Imaging Sweden AB (Sweden).
He also served on the board at Stanmore Implants Worldwide Ltd. and Gresham's School.
He received his graduate degree from the University of Cambridge and a doctorate degree from the University of London.